Concepedia

Novel, potent and selective 17β-hydroxysteroid dehydrogenase type 2 inhibitors as potential therapeutics for osteoporosis with dual human and mouse activities

Enrico Perspicace, Liliana Cozzoli, Emanuele M. Gargano, Nina Hanke, Angelo Carotti, Rolf W. Hartmann, Sandrine Marchais‐Oberwinkler

European Journal of Medicinal Chemistry · 2014 · 17 citations · 38 references

DOIFull text

Open access

Concepts

References

38

Osteoporosis Prevention, Diagnosis, and Therapy

JAMA · 2001 · 5.4K citations

Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>

Bruce Ettinger · JAMA · 1999 · 3.4K citations

Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis

Stavros C. Manolagas · Endocrine Reviews · 2000 · 1.3K citations

, , +8

Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women

Elizabeth Barrett‐Connor, Lori Mosca, Peter Collins et al. · New England Journal of Medicine · 2006 · 1K citations · Full text

Alendronate for the Treatment of Osteoporosis in Men

Eric Orwoll, Mark P. Ettinger, Stuart Weiss et al. · New England Journal of Medicine · 2000 · 971 citations · Full text